Catalent Pharma Solutions, Inc. (CTLT)

Catalent Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Cash & Equivalents	55.7	106.4	139	205.1	164	63.9
Cash & Short-Term Investments	55.7	106.4	139	205.1	164	63.9
Cash Growth	-36.34%	-23.45%	-32.23%	25.06%	156.65%	-11.74%
Accounts Receivable	344.2	358	338.3	262.1	236.7	252.4
Receivables	344.2	358	338.3	262.1	236.7	252.4
Inventory	167.3	136.7	130.4	141.5	148.3	194.1
Prepaid Expenses	12.1	16.2	24.2	16.4	18.1	18.2
Other Current Assets	31.8	44.3	54.2	112.6	97.9	61.7
Total Current Assets	627.4	677.9	704.7	757.7	682.5	606
Property, Plant & Equipment	837.6	814.5	809.7	721.3	719.4	810.4
Goodwill	1,088	1,023	1,030	906	848.9	1,083
Other Intangible Assets	363.3	372.2	417.7	286.7	296.6	396.5
Long-Term Deferred Tax Assets	132.2	132.2	135.2	114.8	138.3	184.4
Long-Term Deferred Charges	14.8	18.2	22.6	29.9	34.3	42.4
Other Long-Term Assets	27.4	18.4	19.2	14.8	7.4	9.4
Total Assets	3,091	3,057	3,139	2,831	2,727	3,132

Liabilities

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Accounts Payable	130.3	150.8	134.2	123.7	120.3	127
Accrued Expenses	152.9	150.6	170.5	151.6	130.6	136
Current Portion of Long-Term Debt	27.2	32.9	66.4	52.1	54.2	88.7
Current Portion of Leases	-	2.1	-	-	-	-
Current Income Taxes Payable	45.2	30.7	31.4	22.3	28.2	4.8
Current Unearned Revenue	52.2	36.3	25.4	15.5	19.6	7.6
Other Current Liabilities	4.6	6	9.8	19.6	28.9	6.2
Total Current Liabilities	413.3	410.3	439.3	385.5	382	386.5
Long-Term Debt	2,674	2,596	2,640	2,337	2,271	2,287
Long-Term Leases	-	60.4	-	-	-	-
Long-Term Deferred Tax Liabilities	213.1	219.1	219.9	192.7	198.7	236.6
Other Long-Term Liabilities	52	47	49.8	47.7	38.6	36.8
Total Liabilities	3,487	3,467	3,490	3,041	2,991	3,051

Shareholders' Equity

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Additional Paid-In Capital	1,031	1,027	1,024	1,082	1,074	1,071
Retained Earnings	-1,440	-1,429	-1,382	-1,342	-1,288	-998.1
Comprehensive Income & Other	8.8	-9.3	7.5	46	-48.5	4.5
Total Common Equity	-400	-410.7	-350.7	-213.7	-262	77.4
Minority Interest	4.1	0.4	-	3.8	-1.5	3.1
Shareholders' Equity	-395.9	-410.3	-350.7	-209.9	-263.5	80.5
Total Liabilities & Equity	3,091	3,057	3,139	2,831	2,727	3,132

Additional Metrics

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Total Debt	2,701	2,692	2,707	2,389	2,325	2,375
Net Cash (Debt)	-2,646	-2,585	-2,568	-2,184	-2,161	-2,312
Net Cash Growth	-	-	-	-	-	-
Working Capital	214.1	267.6	265.4	372.2	300.5	219.5
Tangible Book Value	-1,852	-1,806	-1,798	-1,406	-1,408	-1,402
Land	615	552.7	527.3	420.4	389.7	403.9
Machinery	682.9	650.6	594.7	556.3	500.5	546.4
Construction In Progress	67.7	61.6	54.2	50.9	69	56.8

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2014

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2025

Data Sources Report a data error